Leukemia & Lymphoma, Volume 62, Issue 9 (2021)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 62, Issue 9 (2021)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Volume 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Too much, or not enough? The enduring uncertainty of maintenance rituximab for transformed follicular lymphoma
Adrian Minson & Michael Dickinson
Pages: 2047-2049
Published online: 09 Jun 2021
First Page PreviewforToo much, or not enough? The enduring uncertainty of maintenance rituximab for transformed follicular lymphoma | Full Text | References | PDF (301.6 KB) | EPUB
  • 184 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Measurable residual disease negativity in acute myeloid leukemia: the destination may matter more than the journey
Maximilian Stahl, Martin S. Tallman & Aaron D. Goldberg
Pages: 2050-2051
Published online: 14 Sep 2021
CitationforMeasurable residual disease negativity in acute myeloid leukemia: the destination may matter more than the journey | Full Text | References | PDF (244.1 KB) | EPUB
  • 113 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

Review
Resistance to CART cell therapy: lessons learned from the treatment of hematological malignancies
Reona Sakemura, Michelle J. Cox, Mehrdad Hefazi, Elizabeth L. Siegler & Saad S. Kenderian
Pages: 2052-2063
Published online: 08 Mar 2021
AbstractforResistance to CART cell therapy: lessons learned from the treatment of hematological malignancies | Full Text | References | PDF (1.7 MB) | EPUB
  • 1217 Views
  • 6 CrossRef citations
  • 0Altmetric
Review
Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia
Shady Adnan-Awad, Matti Kankainen & Satu Mustjoki
Pages: 2064-2078
Published online: 04 May 2021
AbstractforMutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia | Full Text | References | PDF (1.7 MB) | EPUB
  • 7489 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access
Review
Penicillium genus as a source for anti-leukemia compounds: an overview from 1984 to 2020
Ana Calheiros de Carvalho, Claudio Yoshio Ogawa Junior, Luiza De Camillis Rodrigues, Lívia Soman de Medeiros & Thiago André Moura Veiga
Pages: 2079-2093
Published online: 18 Mar 2021
AbstractforPenicillium genus as a source for anti-leukemia compounds: an overview from 1984 to 2020 | Full Text | References | PDF (1.7 MB) | EPUB
  • 210 Views
  • 7 CrossRef citations
  • 0Altmetric

Original Articles

Article
Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma*
Wyndham H. Wilson, Tycel Phillips, Leslie Popplewell, Sven de Vos, Saurabh Chhabra, Amy S. Kimball, Darrin Beaupre, Da Wei Huang, George Wright, Kevin Kwei, Jerry Ping, Jutta K. Neuenburg & Louis M. Staudt
Pages: 2094-2106
Published online: 15 Apr 2021
AbstractforPhase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma* | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 2978 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access
Article
Overall and event-free survival of childhood lymphoma in Greece: analysis of harmonized clinical data over a 24-year active registration period
Maria A. Karalexi, Apostolos Pourtsidis, Paraskevi Panagopoulou, Maria Moschovi, Sophia Polychronopoulou, Maria Kourti, Emmanuel Hatzipantelis, Eftichia Stiakaki, Helen Dana, NARECHEM-ST collaborating group, Panagiota Bouka, Evangelia E. Ntzani & Eleni Th. Petridou
Pages: 2107-2119
Published online: 11 Jun 2021
AbstractforOverall and event-free survival of childhood lymphoma in Greece: analysis of harmonized clinical data over a 24-year active registration period | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 132 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Molecular characterization of Burkitt lymphoma in the breast or ovary
Shaymaa Elgaafary, Cristina López, Inga Nagel, Inga Vater, Susanne Bens, Monika Szczepanowski, Sietse M. Aukema, Rabea Wagener, Lydia Hopp, Hans Binder, Laurence de Leval, Wolfram Klapper & Reiner Siebert
Pages: 2120-2129
Published online: 24 Jun 2021
AbstractforMolecular characterization of Burkitt lymphoma in the breast or ovary | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 361 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Subcutaneous panniculitis-like T-cell lymphoma, lupus erythematosus profundus, and overlapping cases: molecular characterization through the study of 208 genes
Salma Machan, Marta Rodríguez, Ruth Alonso-Alonso, Rebeca Manso, Sandra Pérez-Buira, Jennifer Borregón, José Luis Rodríguez-Peralto, Lorenzo Cerroni, Rosario Haro, Candelaria García, Enrique García Toro, Teresa Estrach, Adriana García-Herrera, Berta Ferrer, Carlos González-Cruz, Nerea Segues, Juan Luis Afonso-Martin, Yeray Peñate, Carlos Monteagudo, Miguel Ángel Limeres-Gonzalez, María Ángeles González-Núñez, Maria Ángeles Torres-Nieto Torres, Laura Cereceda, Raúl Córdoba, Miguel Ángel Piris, Luis Requena & Socorro María Rodríguez-Pinilla
Pages: 2130-2140
Published online: 08 May 2021
AbstractforSubcutaneous panniculitis-like T-cell lymphoma, lupus erythematosus profundus, and overlapping cases: molecular characterization through the study of 208 genes | Full Text | References | PDF (2.9 MB) | EPUB | Supplemental
  • 568 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma
Hideki Uryu, Yuko Mishima, Naoko Tsuyama, Masahiro Yokoyama, Noriko Nishimura, Takanori Fukuta, Yuko Shirouchi, Takashi Okabe, Norihito Inoue, Kengo Takeuchi & Yasuhito Terui
Pages: 2141-2150
Published online: 21 Mar 2021
AbstractforRituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 620 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Different chemokine profile between systemic and testicular diffuse large B-cell lymphoma
Riina K. Ollikainen, Pyry H. Kotkaranta, Janette Kemppainen, Hanna-Riikka Teppo, Hanne Kuitunen, Risto Pirinen, Taina Turpeenniemi-Hujanen, Outi Kuittinen & Milla E.L. Kuusisto
Pages: 2151-2160
Published online: 15 Apr 2021
AbstractforDifferent chemokine profile between systemic and testicular diffuse large B-cell lymphoma | Full Text | References | PDF (1.8 MB) | EPUB
  • 197 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Rituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation
Clarisse Cazelles, Karim Belhadj, Hélène Vellemans, Vincent Camus, Elsa Poullot, Philippe Gaulard, Liana Veresezan, Emmanuel Itti, Stéphanie Becker, Muriel Carvalho, Jehan Dupuis, Fabien Le Bras, François Lemonnier, Louise Roulin, Taoufik El Gnaoui, Fabrice Jardin, Nicolas Mounier, Hervé Tilly & Corinne Haioun
Pages: 2161-2168
Published online: 25 Mar 2021
AbstractforRituximab plus gemcitabine and oxaliplatin (R-GemOx) in refractory/relapsed diffuse large B-cell lymphoma: a real-life study in patients ineligible for autologous stem-cell transplantation | Full Text | References | PDF (1 MB) | EPUB
  • 13109 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Article
Postinfusion monitoring costs by site of care for patients with relapsed/refractory large B-cell lymphoma receiving third- or later-line treatment with lisocabtagene maraleucel in the TRANSCEND NHL 001 and OUTREACH trials
M. Lia Palomba, Monika Parisi Jun, James Lymp, Andy Nguyen, November McGarvey, Matthew Gitlin, Corey Pelletier, Scott J. Keating & John Godwin
Pages: 2169-2176
Published online: 21 May 2021
AbstractforPostinfusion monitoring costs by site of care for patients with relapsed/refractory large B-cell lymphoma receiving third- or later-line treatment with lisocabtagene maraleucel in the TRANSCEND NHL 001 and OUTREACH trials | Full Text | References | PDF (960.5 KB) | EPUB
  • 516 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience
Zachary D. Epstein-Peterson, Nivetha Ganesan, Juliet N. Barker, Pamela R. Drullinsky, Paola Ghione, Ann A. Jakubowski, Anita Kumar, Alison J. Moskowitz, Ariela Noy, Miguel-Angel Perales, Doris M. Ponce, Heiko Schoder, James W. Young, Sergio A. Giralt, Steven M. Horwitz, Craig S. Sauter & Parastoo B. Dahi
Pages: 2177-2183
Published online: 29 Mar 2021
AbstractforOutcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience | Full Text | References | PDF (656.1 KB) | EPUB
  • 298 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia
Lydia L. Benitez, Anthony J. Perissinotti, Caitlin R. Rausch, Jeff Klaus, Stephen Michael Clark, Michael Filtz, Kelley Ratermann, Carissa Treptow, Shawn Griffin, Marissa Olson, Mallory Crain, Tapan Kadia, Kristen Pettit, Patrick W. Burke, Dale L. Bixby & Bernard L. Marini
Pages: 2184-2192
Published online: 08 Apr 2021
AbstractforMulticenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia | Full Text | References | PDF (1 MB) | EPUB
  • 844 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Inferior outcomes with reduced intensity conditioning followed by allogeneic hematopoietic cell transplantation in fit individuals with acute lymphoblastic leukemia: a Canadian single-center study and a comparison to registry data
Ivan Pasic, Kristjan Paulson, Graham Dozois, Kirk R. Schultz, Jeffrey H. Lipton & Rajat Kumar
Pages: 2193-2201
Published online: 08 Apr 2021
AbstractforInferior outcomes with reduced intensity conditioning followed by allogeneic hematopoietic cell transplantation in fit individuals with acute lymphoblastic leukemia: a Canadian single-center study and a comparison to registry data | Full Text | References | PDF (949.3 KB) | EPUB
  • 207 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Is acute lymphoblastic leukemia with mature B-cell phenotype and KMT2A rearrangements a new entity? A systematic review and meta-analysis
Gloria Hidalgo-Gómez, Carlos Palacio-Garcia, Laura Gallur, Adoración Blanco, Bárbara Tazón-Vega, Silvia Saumell, Noemí Martínez, Laura Murillo, Thais Murciano, Pablo Velasco, Francesc Bosch, Cristina Diaz-Heredia & Margarita Ortega
Pages: 2202-2210
Published online: 07 Apr 2021
AbstractforIs acute lymphoblastic leukemia with mature B-cell phenotype and KMT2A rearrangements a new entity? A systematic review and meta-analysis | Full Text | References | PDF (1 MB) | EPUB
  • 348 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Long-term ovarian reserve and fertility outcomes in female survivors of childhood acute lymphoblastic leukemia
Sarah Elitzur, Shani Frank, Tal Goshen-Lago, Shlomit Barzilai-Birenboim, Gil Gilad, Galia Avrahami, Tracie Goldberg, Naomi Litichever, Ameena Masarwa, Galia Oron, Isaac Yaniv, Shai Izraeli & Irit Ben-Aharon
Pages: 2211-2218
Published online: 22 Mar 2021
AbstractforLong-term ovarian reserve and fertility outcomes in female survivors of childhood acute lymphoblastic leukemia | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 323 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Venous thromboembolism in patients with multiple myeloma receiving daratumumab-based regimens: a post hoc analysis of phase 3 clinical trials
Jiasheng Wang, Changsu Park & Raul Arroyo-Suarez
Pages: 2219-2226
Published online: 09 Apr 2021
AbstractforVenous thromboembolism in patients with multiple myeloma receiving daratumumab-based regimens: a post hoc analysis of phase 3 clinical trials | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 382 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Involved free light chain: an early independent predictor of response and progression in multiple myeloma
Charlotte Gran, Gabriel Afram, Johan Liwing, Andre Verhoek & Hareth Nahi
Pages: 2227-2234
Published online: 02 Apr 2021
AbstractforInvolved free light chain: an early independent predictor of response and progression in multiple myeloma | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 2563 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Role of D(T)PACE-based regimens as treatment of multiple myeloma with extramedullary relapse or refractory disease
Tony Huynh, Elise Corre, Marie-Paule Lemonnier, Rémy Duléry, Zora Marjanovic, Nabaz Jaff, Simona Lapusan, Mohamad Mohty, Laurent Garderet & Paul Coppo
Pages: 2235-2241
Published online: 01 Apr 2021
AbstractforRole of D(T)PACE-based regimens as treatment of multiple myeloma with extramedullary relapse or refractory disease | Full Text | References | PDF (686 KB) | EPUB | Supplemental
  • 336 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
SPAG6-silencing enhances decitabine-induced apoptosis and demethylation of PTEN in SKM-1 cells and in a xenograft mouse model
Jie Luo, Jiao Mu, Meng Zhang, Beibei Zhao & Lin Liu
Pages: 2242-2252
Published online: 10 Apr 2021
AbstractforSPAG6-silencing enhances decitabine-induced apoptosis and demethylation of PTEN in SKM-1 cells and in a xenograft mouse model | Full Text | References | PDF (2.9 MB) | EPUB
  • 196 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Myeloproliferative neoplasm questionnaire: assessing patient disease knowledge in the modern digital information era
Naveen Pemmaraju, Nathaniel R. Wilson, Theresa Clementi Doan, Wei Qiao, Susan K. Peterson, Vicky Zoeller, Andrew Schorr & Srdan Verstovsek
Pages: 2253-2260
Published online: 22 Mar 2021
AbstractforMyeloproliferative neoplasm questionnaire: assessing patient disease knowledge in the modern digital information era | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 270 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience
Sara Pepe, Emilia Scalzulli, Gioia Colafigli, Alessio Di Prima, Marco Mancini, Daniela Diverio, Roberto Latagliata, Maurizio Martelli, Robin Foà & Massimo Breccia
Pages: 2261-2266
Published online: 16 Mar 2021
AbstractforLong-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience | Full Text | References | PDF (678.7 KB) | EPUB
  • 121 Views
  • 0 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Low dose stereotactic irradiation and dexamethasone in primary cerebral light chain deposition disease (LCDD)
Daniel Authier, Ute Hegenbart, Fabian Pohl, Andreas Rosenwald, Stefan Kircher, Karin Menhart, Markus Perl, Jindrich Cerny, Stephanie Mayer, Wolfgang Herr & Matthias Grube
Pages: 2267-2271
Published online: 31 Mar 2021
First Page PreviewforLow dose stereotactic irradiation and dexamethasone in primary cerebral light chain deposition disease (LCDD) | Full Text | References | PDF (1.7 MB) | EPUB
  • 93 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Prognostic relevance of lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience
Juliette Pénichoux, Sydney Dubois, Daphné Krzisch, Anne-Lise Menard, Hélène Lanic, Vincent Camus, Emilie Lemasle, Stéphane Leprêtre, Pascal Lenain, Nathalie Contentin, Sylvie Daliphard, Gérard Buchonnet, Dominique Penther, Christian Bastard, Hervé Tilly, Fabrice Jardin & Aspasia Stamatoullas
Pages: 2272-2275
Published online: 02 Apr 2021
First Page PreviewforPrognostic relevance of lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience | Full Text | References | PDF (548.4 KB) | EPUB
  • 104 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Acute megakaryoblastic leukemia with a novel GATA1 mutation in a second trimester stillborn fetus with trisomy 21
Arturo Bonometti, Gessica Lobascio, Emanuela Boveri, Stefania Cesari, Mauro Lecca, Alessia Arossa, Arsenio Spinillo, Edoardo Errichiello & Marco Paulli
Pages: 2276-2279
Published online: 30 Mar 2021
First Page PreviewforAcute megakaryoblastic leukemia with a novel GATA1 mutation in a second trimester stillborn fetus with trisomy 21 | Full Text | References | PDF (1.8 MB) | EPUB
  • 159 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
New dead/H-box helicase gene (ddx41) mutation in an Italian family with recurrent leukemia
Francesca Fazio, Martina Quintini, Ida Carmosino, Caterina Matteucci, Eleonora Miulli, Fabrizia Pellanera, Benedetta Lucani, Michela Ansuinelli, Massimo Breccia, Cristina Mecucci & Roberto Latagliata
Pages: 2280-2283
Published online: 09 Apr 2021
First Page PreviewforNew dead/H-box helicase gene (ddx41) mutation in an Italian family with recurrent leukemia | Full Text | References | PDF (658.1 KB) | EPUB
  • 175 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Hepatitis B immunoglobulin (HBIG) combined with long-term entecavir prophylaxis for hepatitis B virus infection in allogeneic hematopoietic stem cell transplantation with hepatitis B surface antigen-positive donors
Yaoyao Shen, Jiaqian Qi, Yi Wang, Jia Chen, Yi Fan, Ying Wang, Depei Wu & Yang Xu
Pages: 2284-2287
Published online: 18 Mar 2021
First Page PreviewforHepatitis B immunoglobulin (HBIG) combined with long-term entecavir prophylaxis for hepatitis B virus infection in allogeneic hematopoietic stem cell transplantation with hepatitis B surface antigen-positive donors | Full Text | References | PDF (567 KB) | EPUB | Supplemental
  • 136 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center
Cecilia Carpio, Gloria Iacoboni, Guillermo Villacampa, Eva Catalá, Sabela Bobillo, Ana Pérez, Moraima Jiménez, Laura Segura, Mireia Olivé, Anna Farriols, Pau Abrisqueta, David Valcárcel, María Josep Carreras, Francesc Bosch & Pere Barba
Pages: 2288-2291
Published online: 24 Apr 2021
First Page PreviewforSelection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 369 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Venetoclax with chemotherapy in relapse/refractory early T-cell precursor acute lymphoblastic leukemia
Sankalp Arora, Pankit Vachhani, Kimo Bachiashvili & Omer Jamy
Pages: 2292-2294
Published online: 10 Mar 2021
First Page PreviewforVenetoclax with chemotherapy in relapse/refractory early T-cell precursor acute lymphoblastic leukemia | Full Text | References | PDF (303.4 KB) | EPUB
  • 676 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia
Jill Fulcher, Philip Berardi, Grace Christou, Pierre J. A. Villeneuve, Christopher Bredeson & Mitchell Sabloff
Pages: 2295-2297
Published online: 21 Mar 2021
First Page PreviewforNelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia | Full Text | References | PDF (672.5 KB) | EPUB
  • 634 Views
  • 6 CrossRef citations
  • 0Altmetric

Correction

Correction
Correction
Page: 2298
Published online: 28 Sep 2021
CitationforCorrection | Full Text | PDF (93.9 KB) | EPUB
  • 569 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles